| Product Name |
Afatinib Inhouse Impurity 17 / (S)-Diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No |
618061-76-0 |
| Catalog Number |
GS.25.AFT.47 |
| Chemical Name/Synonyms |
Diethyl (S)-(2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate ; Diethyl P-[2-[[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]amino]-2-oxoethyl]phosphonate |
| Molecular Weight |
552.91 |
| Molecular Formula |
C24H27ClFN4O6P |
| Purity |
NLT 95% |
| Appearance |
Pale yellow to light beige crystalline solid |
| Applications |
Afatinib, an FDA-approved targeted cancer medication used to treat certain types of non-small cell lung cancer |
| Inventory Status |
Ready Stock
Please as a distributor to view package sizes and prices
|
